P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses

Lignende værker

• Altering an Artificial Gagpolnef Polyprotein and Mode of ENV Co-Administration Affects the Immunogenicity of a Clade C HIV DNA Vaccine
  af: Böckl, Katharina, et al.
  Udgivet: (2012)
• P10-10. HIV-1 Gag virus like particles pseudotyped with CD40 ligand to stimulate innate immune responses
  af: Köstler, J, et al.
  Udgivet: (2009)
• P04-32. Differential regulation of secondary antibody responses to Gag and Env proteins
  af: Nabi, G, et al.
  Udgivet: (2009)
• The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
  af: Zembe, L, et al.
  Udgivet: (2012)
• P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial
  af: Fellay, J, et al.
  Udgivet: (2009)